Financials
- Market Capitalization 1.49 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-14.67
ratio cours/chiffre d'affaires
1 072.51
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2179 | NVAX Novavax, Inc. - Common Stock | 9.26 USD | +2.32% | +4.28% | +25.82% | +25.30% | 1.53 B USD | ||
| 2184 | INVA Innoviva, Inc. - Common Stock | 20.97 USD | +0.05% | -0.47% | 0.00% | +17.68% | 1.51 B USD | ||
| 2195 | TYRA Tyra Biosciences, Inc. - Common Stock | 24.94 USD | -4.55% | -4.04% | -19.70% | +73.92% | 1.49 B USD | ||
| 2198 | AVBP ArriVent BioPharma, Inc. - Common Stock | 30.17 USD | -2.68% | +3.96% | +2.31% | +55.92% | 1.49 B USD |